Guardant Health
GH
#1003
Rank
C$33.99 B
Marketcap
C$253.31
Share price
1.75%
Change (1 day)
189.01%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

EPS for Guardant Health (GH)

EPS in 2026 (TTM): C-$4.86

According to Guardant Health 's latest financial reports the company's current EPS (TTM) is C-$4.97. In 2025 the company made an earnings per share (EPS) of C-$4.72 an increase over its 2024 EPS that were of C-$5.07.

EPS history for Guardant Health from 2018 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C-$4.863.06%
2025C-$4.72-7.02%
2024C-$5.07-16.82%
2023C-$6.10-33.13%
2022C-$9.1260%
2021C-$5.7055.04%
2020C-$3.68207.14%
2019C-$1.20-19.81%
2018C-$1.49

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Neogen
NEOG
C-$0.05126-98.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
C-$3.49-29.80%๐Ÿ‡บ๐Ÿ‡ธ USA